Redesign Health Raises $175M to Help More Startups Succeed
Startup creator Redesign Health, which empowers founders to launch and scale healthcare companies, has closed a $175 million investment for a new fund.
Since 2018, New York-based Redesign Health has supported founders in launching more than 60 companies that have generated more than $1 billion in revenue.
Redesign Health is focused on launching companies in eight areas where it says that innovation can drive the greatest impact:
• Addressing the healthcare labor shortage
• Accelerating value-based and longitudinal care
• Advancing healthcare interoperability
• Preparing for an aging population
• Eliminating barriers to health equity
• Expanding sites of care
• Growing the insured population
• Driving healthcare personalization and consumerization
"Healthcare founders today benefit from unprecedented tailwinds. AI, aligned payment models, patient demand for better care, and unsustainable cost pressures set the stage for generational value creation and social impact," said Brett Shaheen, founder and CEO of Redesign Health, in a statement. "At the same time, building healthcare companies is really hard. Founders encounter opaque value chains, complex regulations, long sales cycles, and almost no tolerance for error. We built Redesign to help founders overcome these challenges and capture a historic opportunity to accelerate innovation in service of patients.”
Redesign Health's model involves working with founders across all stages of their journey in three key areas. The company said it offers deep institutional knowledge and hands-on support for ideation and diligence, powered by proprietary research tools and a vast network of industry experts. Its platform accelerates commercial traction through pre-existing relationships with hundreds of healthcare companies and scalable demand generation systems. Additionally, founders benefit from comprehensive execution support, including an engaged founder community, extensive investor and talent networks, and healthcare-specific operational expertise.
The fund includes participation from Declaration Partners, Euclidean Capital and True North Advisors.
